ALS NEWS - May 15, 2020
QurAlis, a corporation based in Massachusettes, Boston has invested $42 million toward the research and development of ALS treatments. This is such a ... Read More
ALS NEWS - May 03, 2020
Living with ALS can prompt all sorts of questions regarding COVID-19.
What is COVID-19?
How do I protect myself?
How do I protect my loved ones?
... Read More
ALS NEWS - April 28, 2020
The lack of biomarkers, or clinical tests to determine an ALS diagnosis, are a deep frustration for patients and the scientific community alike. In a... Read More
ALS NEWS - January 17, 2020
Many ALS specialists and patients consider the techniques used in the current ALS disability test, the ALSFRS-R, to be ineffective. Functional rating scal... Read More
ALS NEWS - October 31, 2019
Taking a new approach to fighting ALS, a new drug that heals mitochondria in nerve cells is now moving on to in-human studies. This drug, called SBT-272, has be... Read More
ALS NEWS - October 28, 2019
A new oral drug is in development for ALS patients to prevent nerve damage. With few drugs in the clinic for ALS patients today, the potential to have new treat... Read More
ALS NEWS - October 21, 2019
Treatment of ALS drug SBT-272 on mouse models shows promising results. Stealth bioTherapeutics recently announced that they are making plans to move on to a Pha... Read More
ALS NEWS - September 12, 2019
Tim Green, a former NFL player, is fighting against ALS and is working tirelessly to find a cure. On 60 Minutes Tim and his son Troy Green, give us insight into... Read More
ALS NEWS - August 30, 2019
A recent paper was written on Parkinson’s disease showing that two conditions - oxidative stress and proteinopathy - may help find the cause o... Read More
ALS NEWS - August 08, 2019
The FDA recently granted the status of 'orphan drug' to APB-102, a potential gene therapy for familial ALS. Orphan drug status is given to terminal dise... Read More